Parallel Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-350
| Closed | – | – | 3649 |
|
|
2024
Q3 | $0 | Hold |
350
| – | – | ﹤0.01% | 3520 |
|
|
2024
Q2 | $0 | Hold |
350
| – | – | ﹤0.01% | 3468 |
|
|
2024
Q1 | $13 | Hold |
350
| – | – | ﹤0.01% | 3250 |
|
|
2023
Q4 | $19 | Hold |
350
| – | – | ﹤0.01% | 3269 |
|
|
2023
Q3 | $31 | Hold |
350
| – | – | ﹤0.01% | 3304 |
|
|
2023
Q2 | $32 | Hold |
350
| – | – | ﹤0.01% | 3314 |
|
|
2023
Q1 | $91 | Hold |
350
| – | – | ﹤0.01% | 3338 |
|
|
2022
Q4 | $74 | Hold |
350
| – | – | ﹤0.01% | 3279 |
|
|
2022
Q3 | $0 | Hold |
350
| – | – | ﹤0.01% | 3675 |
|
|
2022
Q2 | $0 | Hold |
350
| – | – | ﹤0.01% | 3535 |
|
|
2022
Q1 | $0 | Hold |
350
| – | – | ﹤0.01% | 3454 |
|
|
2021
Q4 | $0 | Hold |
350
| – | – | ﹤0.01% | 3470 |
|
|
2021
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 3012 |
|
|
2021
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 2880 |
|
|
2021
Q1 | $1K | Hold |
350
| – | – | ﹤0.01% | 2742 |
|
|
2020
Q4 | $1K | Hold |
350
| – | – | ﹤0.01% | 2524 |
|
|
2020
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 2516 |
|
|
2020
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 2408 |
|
|
2020
Q1 | $0 | Buy |
+350
| New | – | ﹤0.01% | 2802 |
|